This is an archived webpage for the 2022 Annual Meeting.
View the up-to-date information for the 2024 Annual Meeting.
View the up-to-date information for the 2024 Annual Meeting.
Meet the Exhibitors
2022 Exhibitor List
The industry's top companies will participate in the the ASBrS 23rd Annual Meeting, April 6–10, 2022, in Las Vegas, Nevada, where they will showcase the latest technology and procedures as exhibitors and supporters. You will be able to meet with company representatives and view this technology first-hand while visiting the exhibits.
Company |
Booth |
Company Website |
406 |
||
| 3M, with the acquisition of KCI, focuses on providing better care through patient-centered science. Helping transform patient outcomes by stewarding skin, reducing the risk of preventable complications and restoring lives. From wound and skin care to solutions for BSI and SSI risk reduction, our team is ready to partner with you to strive toward a world with zero complications. | ||
506 |
||
| Agendia is a precision oncology company committed to improving clinical outcomes and informing the journey for patients with early stage breast cancer. Through its state-of-the-art laboratory, the company currently offers two commercially-available genomic profiling tests. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. By developing evidence-based novel genomic tests, Agendia aims to support the evolving clinical needs of breast cancer patients and their physicians. | ||
432 |
||
| Ambry Genetics, as part of REALM IDx, Inc., excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. Our unparalleled track record of discoveries over 20 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means we are first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. We care about what happens to real people, their families, and the people they love, and remain dedicated to providing them and their clinicians with deeper knowledge and fresh insights, so together they can make informed, potentially life-altering healthcare decisions. | ||
326 |
||
| For over 45 years, we’ve been working passionately to help women with breast cancer get their confidence back. Since 1975, we have been your complete partner in the field of breast care with the highest standards of quality, innovation and design. Let’s help build the future and self-confidence of your patients together. To support women on their journey through breast cancer, we offer products adapted to all sorts of specific needs, right from the beginning of treatment. Our high-quality products, strong focus on innovation, and commitment to using only the best materials, we guarantee your patients will be satisfied. We’re proud to support women along their journey – from diagnosis right up to the return to their everyday lives. This is what we call the Amoena Solution and why we’re your partner in breast care. | ||
528 |
||
| Applied Medical designs, develops, manufactures and sterilizes healthcare solutions that enable advanced surgical procedures and optimize patient outcomes. We achieve this while also reducing healthcare costs and offering unrestricted choice. Applied Medical is committed to furthering minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs. | ||
Cristal Foyer |
||
| The American Society of Breast Surgeons Foundation offers free patient education materials and support programs; promotes the work of breast surgeons; and provides community/education program and research grants. Stop by to pick up your free Breast360.org patient cards, participate in Explore for More for a chance at a prize drawing, and learn more about the upcoming Virtual 5K Race for Every Breast Cancer Survivor! | ||
518 |
||
| AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide | ||
429 |
||
| AVATAR MEDICAL is an innovative spin-off from Institut Pasteur and Institut Curie. AVATAR MEDICAL was incorporated in Paris in July 2020 by an experienced team of French and American founders, and also operates in the United States. AVATAR MEDICAL creates patient avatars to help surgeons prepare their surgeries. Our technology instantly creates interactive 3D representations of patients based on standard medical images in an immersive virtual reality context. The company has been selected in prestigious competitions and programs: i-Lab, i-Nov, the MedFIT award for the most innovative European startup, PR[AI]RIE, and the NVIDIA Inception program. Full commercial deployment of the FDA and CE-approved version of the software platform is planned for 2022. | ||
227 |
||
| Bayer: Evolving Radiology Image Acquisition - Welcome to ASBrS 2022. Bayer has been committed to Radiology for more than 80 years and continues to partner with Radiologists to help guide diagnostic imaging led by our purpose that everyone deserves clear answers about their health. We are backed by a global footprint and a passionate team across more than 140 countries. Bayer is dedicated to being a leader in the field of medical imaging to shape the patient experience and help patient outcomes. Medical imaging goes beyond scans and images by providing clear answers – it often marks the starting point and guides the subsequent direction for a patient’s journey. As a life-science company with a heritage of approximately 80 years in Radiology, we can build on our leadership in contrast media and devices. With its comprehensive product portfolio that improves automation, along with unparalleled support and service that maximizes uptime, Bayer is a leader in meeting the needs of Radiology programs and professionals. Bayer products for the Magnetic Resonance (MR) and Computed Tomography (CT) suites in particular, help radiology professionals achieve high-quality diagnostic images to support diagnosis of medical conditions. In addition, Bayer offers an end-to-end support system, ranging from contrast agents and power injections systems and their sterile disposables to equipment service and enterprise informatics. With the combined power of Bayer's MEDRAD® injection systems and diagnostic imaging units, the division transforms insight into research in CT, MRI, PET, and interventional studies to help radiology professionals achieve high-quality diagnostic images consistently and efficiently to support the diagnosis of medical conditions. Bayer is fully committed to driving innovation in medical imaging and to helping answer critical questions in the diagnosis and monitoring of severe diseases, because.... everyone deserves clear answers about their health. | ||
500 |
||
| BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 70,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com | ||
534 |
||
| The TeamBest family of companies has been proudly developing, manufacturing, and delivering reliable medical equipment and supplies for more than 40 years. TeamBest includes over a dozen companies offering complementary products and services for brachytherapy, health physics, radiation oncology, blood irradiation, vascular therapy, imaging, and medical particle acceleration. TeamBest is the single source for an expansive line of life saving medical equipment and supplies. Our trusted team is constantly expanding and innovating to provide the most reliable and cutting edge medical equipment and supplies to the global healthcare and research industries. | ||
427 |
||
| Since 1932, Boiron has been sharing its passion for homeopathy with a holistic and ecological approach to medicine. Its vision of health care puts people at its center and seeks to improve the quality of their everyday lives. Boiron is committed to educating the HCPs on the many benefits homeopathy has to offer and the necessity of modern medicine to heal without harm. | ||
425 |
||
| BOSS Instruments concentrates on the global development and distribution of German-crafted specialty instruments and retractor systems for most surgical specialties. BOSS will be displaying the LightMat® and VersaLight™, which deliver cool, bright light deep into the surgical site for enhanced visualization. Now offering NEW carbon-reinforced handheld retractors! | ||
105 |
||
| Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The Nuclear & Precision Health Solutions division is committed to improving the lives of patients by applying more than 40 years of experience and expertise in nuclear and precision health. The business provides radiopharmaceutical development, manufacturing, preparation, market access, and business solutions across the care delivery continuum from origin to patient administration. As the only national source for both SPECT and PET radiopharmaceuticals with the largest network of 130 pharmacies and 30 cyclotron facilities, we can reach 95% of U.S. hospitals within three hours. We give customers the support they need in regulatory compliance, reimbursement, continuing education, information management and other crucial areas, so they can focus on their patients. Discover how collaborating with us can help you achieve high-quality patient care, operational efficiency and market leadership. Learn more at cardinalhealth.com/nps. | ||
113 |
||
| Southern Scientific has many years of experience and expertise working in the specialist health sector. Indeed, as part of the LabLogic group, the company is a key supplier to the healthcare sector worldwide. We are the manufacturer of the Care Wise C-Trak Apollo Gamma Probe System which provides accurate and precise detection of radiation for use during sentinel node biopsies in breast, melanoma and other types of cancer. The C-Trak Apollo’s distinctive feature is our superior sensitivity and directionality, but now we also offer wired or wireless connectivity with the same probe allowing for complete flexibility. Using our proven OmniProbe® technology, the Apollo offers precise and accurate detection of various isotopes. Its superior directionality means quick and accurate identification of subjects which leads to less dissection and improved procedures. Software for the C-Trak Apollo has been reimagined, with several new features including autoranging capabilities, choice of four audible signals, easier switching between isotopes (such as Tc-99m and I-125), storage of calibration tests and prompts for renewing calibration sources. | ||
443 |
||
| High-definition ultrasound imaging you can trust for Breast Surgery. Clarius HD3 delivers best-in-class portable ultrasound for your specialty, with an easy-to-use app powered by artificial intelligence and connected to the cloud. Manage your exams anywhere and improve patient outcomes with clear, real-time imaging that is easy to use, affordable, and ultra-portable. | ||
315 |
||
| Clarix Imaging brings unprecedented clarity to intraoperative lumpectomy margin visualization with our true 3D VSI-360™ Volumetric Specimen Imaging System. This advanced imaging technology takes breast surgeons and radiologists on a Journey Through the Specimen™ with views of any tissue slice from multiple angles – with no obscuring of the margins. A venture-backed private company founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers radiologists and surgeons unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room. VSI-360™ generates a true 3D image of the specimen in real-time, and its advanced software tools allow users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins. Partner with us on our journey to advance outcomes in surgical oncology through innovations in imaging. | ||
CompAI Healthcare USA |
435 |
|
517 |
||
| DiepCjourney Foundation is a non-profit 501(c)(3) organization providing education and resources to empower those affected by breast cancer with information to make an informed decision about all options for breast reconstruction surgery after a mastectomy. We are here to get get the message out to patients about breast surgery and provide them with services from surgeons that will allow the best in oncologic safety and guidelines as well as optimal aesthetic care and outcomes. | ||
233 |
||
| Dilon Technologies® Inc., a medical device manufacturer based in Newport News, Virginia, strives to improve the quality of life by providing a wide range of innovative medical solutions that benefit patients around the world. Dilon has a strong medical device portfolio; the Navigator System, a trusted brand and world-renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe, a ground breaking technology for accurate margin assessment in breast cancer surgery, which is manufactured at our facility in Ceasarea, Israel, and the CoPilot, an innovative, portable, and easy to use video laryngoscope. | ||
512 |
||
| Elucent Medical has designed the EnVisio™ Navigation system; a novel device that utilizes an innovative electromagnetic field and SmartClip™ to enable precise stereotactic navigation within a wide field of view to a target of interest. The integration of the navigation tool onto the electrocautery device provides real-time guidance in the surgical field to deliver visual and audible indicators that provide Depth, Distance, and Direction to the SmartClip. This integrated system enables increased speed because of the ability to have the EnVisio™ pad providing localization of SmartClips, in addition to the Real-Time Navigation is within the surgeon's hand. The guidance and localization update as the tissue is manipulated during the surgery. The generation of an unprecedentedly large field of the electromagnetic field for navigation, the EnVisio System, and SmartClip technology broaden the treatable patient population expanding SmartClip localization from the breast, and lymph nodes to the head and neck, abdominal soft tissue as well as the lung in the future. Elucent Medical is founded on the continued collaboration of multi-disciplinary physicians who seek to improve patient outcomes. The EnVisio Navigation system addresses the clinical need to meet the broadest patient demographics from simple (single site) to complex (several sites in the breast and axilla) cases allowing individualized treatment. | ||
308 |
||
| Endomag believes everyone deserves access to a better standard of cancer care. Many of the world’s leading physicians and hospitals use our technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. At the heart of our platform is the Sentimag® localization system. The Sentimag® system features a probe which works like a metal detector, and when placed near the skin’s surface is used to detect Endomag’s magnetic seed (Magseed®) or liquid tracer (Magtrace®), for more accurate non-radioactive tissue localization and sentinel node biopsy. To date, the Sentimag® platform has been used in over 300,000 tissue localisations across more than 45 countries and on all six continents that perform breast cancer surgery. The technology has allowed these patients, regardless of hospital setting, to access more precise and less invasive breast cancer treatment. Our technologies are also widely supported by extensive clinical data, with over 8,000 patients featured in Magseed® marker studies, making it the world’s most studied non-radioactive seed technology. | ||
200 |
||
| Exact Sciences A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smart solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard®, Oncotype DX®, and Oncotype MAP™ tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to help optimize cancer treatment decisions. In breast cancer, the Oncotype DX Breast Recurrence Score® test is the only test that has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score® test predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. For more information, visit www.exactsciences.com or www.OncotypeIQ.com | ||
526 |
||
| Geisinger Health System is a regional health care provider to central, south-central and northeastern Pennsylvania. Headquartered in Danville, Pennsylvania, Geisinger services over 3 million patients in 45 counties. Geisinger is a health and wellness organization focused on making better health easier for our communities through primary care, specialty medicine, hospitals, clinics, and health insurance. | ||
530 |
||
| Across the world, we have more than 440 centers offering the latest treatments and technologies that have been proven to help patients achieve the best possible outcomes. For radiation therapy, that includes over 130 centers in the U.S. as well as 14 centers in the U.K., 21 in Spain and 36 in Australia. We also offer urology and pulmonology care in the U.S. in over 170 integrated medical offices. Every year our team sees more than 400,000 people globally. Our purpose is to design care experiences that get the best possible life outcomes. Our goal is to deliver exceptional treatment and care in a way that enhances every aspect of a person’s cancer journey. Joining the GenesisCare team means a commitment to seeing and doing things differently. People centricity is at the heart of what we do—whether that person is a patient, a referring doctor, a partner, or someone in our team. We aim to build a culture of ‘care’ that is patient focused and performance driven. | ||
430 |
||
| Hackensack Meridian Health | ||
300 |
||
| Hologic is a global medical technology company specializing in women’s health—offering innovative solutions for screening, detecting and treating conditions affecting women throughout their lives, including breast and cervical cancer testing, gynecological and skeletal issues; and sexually transmitted diseases. | ||
416 |
||
| IceCure Medical is setting new standards in minimally invasive cryotherapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, our FDA-cleared and CE-marked ProSense® Cryoablation System utilizes Liquid Nitrogen to destroy benign and malignant tumors by freezing them to ultra-low temperatures for optimal tumor destruction. For women with breast tumors, the ProSense® System provides patients with safe and fast in-office cryoablation therapy, with excellent cosmetic results. The ProSense® System is FDA-cleared for the treatment of fibroadenomas and in 2021 was granted FDA Breakthrough Device Designation for treatment of patients with T1 invasive breast cancer and/or patients not suitable for surgical alternatives for the treatment of breast cancer. IceCure is conducting the ICE3 Clinical Trial, the largest multi-center trial for cryoablation of small, low-risk breast cancer. Interim analysis of the ICE3 trial presented during ASBrS 2021 Annual Meeting show promising results - at a mean of 34.83 months following treatment with ProSense®, only 2.06% (4 out of 194 eligible trial patients) experienced cancer recurrence. The ICE3 interim results were also published in the Annals of Surgical Oncology “Cryoablation Without Excision for Low-Risk, Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial” with Dr. Richard Fine, MD, FACS, as the lead author. | ||
501 |
||
| ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health. The SOZO® Digital Health Platform, the world's most advanced, noninvasive BIS device, delivers a precise snapshot of fluid status and tissue composition for lymphedema assessment - all in less than 30 seconds*. Early detection and intervention of lymphedema at the subclinical level before any visible swelling is critical. Offer your patients peace of mind. Know their L-Dex® score with the leading technology for point-of-care lymphedema assessment. Learn more: www.impedimed.com | ||
507 |
||
| INRAD is a developer and manufacturer of innovative breast biopsy products. Our catalog of core biopsy needles, breast biopsy markers, and other interventional products have been designed in conjunction with leading physicians with the goal of improving patient care. We are dedicated to developing and manufacturing innovative medical devices that empower physicians to accurately diagnose and treat their patients. | ||
328 |
||
| Intramedical Imaging is a technology company focused on producing gamma probes for sentinel node biopsy detection. | ||
141 |
||
| Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.Our goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices. Visit www.invitae.com. | ||
333 |
||
| iSono Health's mission is to make personalized and accurate breast care accessible to all women everywhere. Our first product, ATUSA, is an AI-driven 3D ultrasound that allows for automated acquisition of whole breast volume in just 2 minutes without the need for an ultrasound specialist. The ultrasound scanner attaches to a positioning bra that allows for hands-free, repeatable imaging of 3D breast volume. The ATUSA software application integrates advanced Machine Learning engine offering streamlined image acquisition and 3D visualization, as well as localization and segmentation of breast lesions. | ||
222 |
||
| KUBTEC is challenging the status quo of breast cancer surgery and is committed to reducing the excessive number of re-excision surgeries. Through continuous research and development of our proprietary 3D tomosynthesis technology, KUBTEC is empowering surgeons with immediate visualization of surgical margins in the operating theater, helping to reduce re-excision rates, preserve healthy breast tissue, and ultimately improve patient outcomes. At KUBTEC we understand that one of the most important drivers of a positive outcome for breast cancer patients is ensuring clear margins at the time of surgery. This is what drives us to push the boundaries and work to set a new standard of care. Our proprietary award-winning technologies, such as 3D breast specimen tomosynthesis; advanced, high-resolution specimen X-ray imaging; and intelligent workflow management features are allowing us to do just that for every surgeon, radiologist, pathologist, pathologists’ assistant, and patient. | ||
532 |
||
| OPPORTUNITY AWAITS! WANTED: Fellowship trained or experienced breast surgeon needed to join busy breast practice in PASCO, Washington. Come join me in the Pacific Northwest where I care for the patients in the greater Tri Cities and surrounding area. Opportunity for ultrasound biopsy and diagnostic work in the clinic, training is available. Oncoplastics is welcome. Sign on Bonus, Relocation incentive and Student Loan Repayments offered. Great place to live and if you are an outdoor enthusiast or wine connoisseur, this is your place! Contact: L.S. Evans MD, PC, FACS via D. Retter, Mgr. 509-539-1311 | ||
329 |
||
| Lumicell is a technology leader in the field of image-guided cancer surgery focused on innovative technologies with the potential to improve patient outcomes. The company has developed an investigational system, the Lumicell Direct Visualization System (DVS) consisting of a proprietary optical imaging agent, a hand-held probe, and a patient calibrated tumor detection software designed to illuminate cancer cells in real time and allow direct visualization of the breast cavity. The Lumicell DVS is designed to enable surgeons to take action and remove residual cancer in real-time during the initial procedure. This system has the potential to significantly improve surgical outcomes and reduce healthcare costs by eliminating the need for repeat surgeries. For more information, visit www.Lumicell.com | ||
316 |
||
| Join us at ASBrS during our Friday night Symposium! At Mammotome, our expertise and compassion for breast care makes us the indispensable partner to physicians, clinicians and patients. Our drive for innovation is rivaled only by our compassion for the people we serve, from the clinicians and surgeons who demand consistently precise solutions, to the patients and families seeking peace of mind. We boast a comprehensive range of products that create better outcomes in breast care and provide physicians, clinicians and patients with educational resources that guide their journey. Our extensive product portfolio includes Mammotome® breast biopsy devices, specimen radiograph system and tissue markers; distribution of Kubtec’s XPERT® 40 Specimen Radiography System; the Neoprobe® Gamma Detection System; as well as distribution of the Sentimag® Localization Platform including the Magseed® magnetic marker for lesion localization and the Magtrace® lymphatic tracer for radiation-free sentinel lymph node biopsy. The Mammotome brand of products is sold in over 50 different countries throughout the world. Headquartered in Cincinnati, OH, Mammotome has been part of the Danaher Corporation since 2014. For more information, visit Mammotome.com and follow Mammotome on social media (Facebook, LinkedIn, Twitter). | ||
515 |
||
| Maple Tree Cancer Alliance provides individualized exercise training to patients during cancer treatment. We can offer our services on-site, colocated in the cancer center, or virtually. Our research demonstrates significant improvements to patient outcomes, as well as significant savings in health care costs, indicated by reduced ER visits, shorter length of stay, and reductions in 30-day readmissions. We currently serve thousands of patients every year, with more than 50 hospital partnerships across the country. | ||
505 |
||
| Masthead (a division of BFFL Co) is a women-owned business whose management team has decades of experience in medicine, design, garment technology and business operations. Founder Elizabeth Chabner, MD, MPH is a Radiation Oncologist and mastectomy patient dedicated to developing products that enhance comfort, dignity and outcome. Our products complement modern surgical techniques and ensure that women leaving your care feel comfortable and prepared for at-home post-op recovery. We are excited–and honored–to provide state-of-the-art products, constant support and exceptional customer service to you and your patients. You might know us by our flagship Elizabeth Pink Surgical Bra with its proprietary loop and ring drain management system, but our company offerings have grown. Please stop by our booth to learn more about the Masthead line of Surgical and Recovery Bras. | ||
101 |
||
| We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary. | ||
509 |
||
| For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com | ||
216 |
||
| Merit Oncology is dedicated to reducing the burden cancer places on patients and their loved ones. As a provider of world class solutions for the diagnosis, localization, and treatment of cancer, Merit Oncology consistently invests in improving our technologies and innovating new platforms to meet our physicians' needs. The preferred localization solution to treat more patients, the SCOUT® Radar Localization system has been utilized in over 280,000 procedures. SCOUT uniquely can be placed at time of biopsy and prior to neoadjuvant chemotherapy with no interference with MRI imaging. The SCOUT system has been clinically demonstrated to improve patient outcomes, workflow and significantly reduce OR delays. Easing the burden of breast cancer treatment, SAVI® Brachy offers a strut-based approach to tissue-sparing dosimetry and is designed to maximize ease of use during placement while providing unparalleled dose customization. Three-fraction treatment protocol with SAVI allows effective APBI treatment to be completed in as little as 2 days, significantly decreasing contact interactions between patients and medical staff. | ||
228 |
||
| MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat breast cancer patients — and we knew we could do better. Our localization system is precise, easy to use and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our feature product, MOLLI®, replaces a method to localize tumors that was traumatic and uncomfortable with one that is not only kinder – but one that is more accurate, efficient and cost-effective. We look beyond building products to help healthcare get simpler to get better. Learn about Localization+, a system of programs we’re developing to support your breast practice and operations, and to amplify your patient education and advocacy efforts. Together we can reach more patients so they can access the screening and treatment options that are right for them. | ||
400 |
||
| Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. Fast Company named Myriad among the World’s Most Innovative Companies for 2022. For more information, visit www.myriad.com. | ||
332 |
||
| We are the most trusted source of genetics tests for women and their families. From planning a family to prenatal testing to hereditary cancer screening, we help create futures with new possibilities. We believe early genetic insights can change the future for women and their families. That’s why we consistently innovate to build an industry-leading genetic testing portfolio and ensure it’s accessible with ease and flexibility through best-in-class support services. | ||
524 |
||
| # # # About Northwell Health Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 76,000 employees – 18,900 nurses and 4,800 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu | ||
519 |
||
| Not Putting on a Shirt is a 501(c)(3) organization advocating for optimal aesthetic flat closure. | ||
307 |
||
| obp is the leading global developer of single-use, self-contained, illuminating surgical devices. We integrate light with device — making them one — creating effective and simplified single-use solutions. Our innovative products are used in surgery centers and hospitals throughout the U.S., as well as healthcare facilities worldwide. | ||
234 |
||
| OSF HealthCare is an integrated health system owned and operated by The Sisters of the Third Order of St. Francis in Peoria, Illinois. Recognized as one of the top healthcare employers in the United States, we employ more than 23,000 Mission Partners in 147 locations throughout Illinois and Michigan, including nine systemwide service lines and two colleges of nursing. | ||
431 |
||
| Pacira BioSciences, Inc. is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com. | ||
311 |
||
| Perimeter Medical Imaging AI is a pioneering medical technology company driven to transform cancer surgery with advanced imaging tools that address unmet medical needs. Our goal is to advance the standard of care, improve patient outcomes, and lower health care costs. With headquarters in Toronto, Canada and U.S. headquarters in Dallas, Texas, Perimeter technology delivers ultra-high-resolution, real-time imaging to help physicians visualize microscopic tissue structures in the surgical margins. Simply put, we provide the medical community with the clarity needed to make critical decisions in the operating room. Available now across the U.S., Perimeter's S-Series OCT, powered by Optical Coherence Tomography, is designed to examine tissues at the cellular level during surgical procedures, rather than days later when pathology reports come back. Our FDA-cleared technology gives surgeons cross-sectional visualization of surgical margins and excised tissues in real time, with 10x higher image resolution than standard X-ray and ultrasound, and 100x greater than MRI. Our next-generation technology uses ImgAssist AI, a powerful artificial intelligence and machine learning tool designed to assist with visualizing margins. In November 2021, Perimeter received FDA Investigational Device Exemption (IDE) approval and launched a multi-site, randomized clinical trial using Perimeter B-Series OCT with ImgAssist AI. The study evaluates this system against the current standard of care and assesses the impact on re-operation rates for patients undergoing breast conservation surgery. For more information, visit www.perimetermed.com | ||
133 |
||
| Coming soon to market! Please stop by to see PrecisionFNA, “The Better Way to FNA”, a new device for any soft tissue FNA. It offers better stabilization, greater precision and improved accuracy, uses fine motor skills, single-handed use, improved ergonomics for the operator and offers improved safety on small peri-vascular or peri-neural lesions. | ||
410 |
||
| PreludeDx is the leading personalized breast cancer diagnostics company dedicated to improving outcomes for patients diagnosed with DCIS (Ductal Carcinoma in Situ). The company provides patients and physicians with evidence-based tools to improve patient outcomes and reduce the cost to the healthcare system by helping to ensure women are not over or under treated. For women diagnosed with DCIS, PreludeDx provides a patented molecular test (DCISionRT®) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery. Visit PreludeDx.com | ||
331 |
||
| Premier Surgical Network offers comprehensive breast and general surgical procedures with convenient office locations throughout New Jersey. All of our surgeons are committed to providing patients with a warm and welcoming environment and offer their support every step of the way from diagnosis to remission. | ||
111 |
||
| Numbness caused by nerves cut during a mastectomy is a problem that can impact long-term quality of life in a multitude of ways. Resensation® is a highly advanced surgical technique of performing breast neurotization using allograft nerve tissue developed by Axogen. | ||
129 |
||
| Silbiotech featuring the BBDRisk Dx® Test. The BBDRisk Dx® Test (Benign Breast Disease Risk) is a new tumor biology based genomic test designed to address the dilemma in treating atypical hyperplasias. Studies show that ~20% of atypical patients develop cancer. The BBDRisk Dx® Test assesses multiple cancer markers in FFPE atypical tissues by IHC, generates a ‘Risk Score’ from 0-10 and categorizes the patient into a Low, Intermediate or High Risk group. Cancer rates in the low risk group are less than 3% over 15 years. Cancer rates in the high risk group are 75% in the first five years after atypia diagnosis. In the intermediate group cancer rates are less than 20% over 15 years. BBDRisk Dx® was validated in 550 clinical samples. BBDRisk Dx® offers for the first time assessment of a patient’s personalized risk level. Clinicians can now make informed treatment decisions in managing atypias. | ||
422 |
||
| About Sirius Medical - With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions to help physicians and hospitals manage growth and control costs. Pintuition® powered by GPSDetect™ is CE marked and FDA 510(k) cleared. The system is an intuitive, wire-free surgical navigation system with a unique multi-sensor probe that provides real-time directional guidance using audio and visual feedback for unmatched precision to locate tumors easily and accurately. Sirius Medical has an experienced and dedicated US team to support customer implementation, training and support. | ||
337 |
||
| Spartanburg Regional Healthcare System is an integrated healthcare delivery system that provides care from one’s birth through the senior years. We’ve been a partner with the community for 100 years and have earned a reputation for technological excellence. Spartanburg Regional Health Services District, Inc. is a self-funded, political subdivision of the state of South Carolina and does not receive tax dollars from the community. Gibbs Cancer Center & Research Institute, with four locations across the Upstate, including Spartanburg, Greer, Gaffney and Union. At Gibbs Cancer Center & Research Institute, we provide you with the friendliness and warmth of a community hospital and the advanced level of care you’d expect from an academic medical center. Every patient’s case is reviewed by teams of healthcare professionals that specialize in each patient’s specific type of cancer – these meetings are called multidisciplinary conferences. With our commitment to bringing together multiple specialists to create the best treatment plan for you, and our strong clinical research program, we’re delivering the highest standard of patient-centered cancer care to the entire Upstate South Carolina region. | ||
322 |
||
| Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. Stryker’s SPY fluorescence imaging technology allows surgeons to assess tissue perfusion before, during and after plastic and reconstructive surgical procedures. This brilliant visualization may help surgeons achieve improved outcomes for patients undergoing breast cancer surgery. Stryker Surgical Technologies offers innovative solutions to everyday hazards in the OR, and has expanded to breast reconstructive surgery. With a mission of zero blind spots during surgery, our illuminator retractors are designed to provide strong, volumetric light output whilst remaining thermally cool, enabling superior visualization. | ||
319 |
||
| Terason continues to revolutionize ultrasound with the latest developments in high performance portable systems. Our uSmart NexGen Ultrasound Systems provide exceptional imaging capability and advanced features such as SuperHarmonic Imaging and Advanced Needle Visualization (ENV) increasing efficiency while minimizing complications for improved patient care. Terason's new 3200T Plus with its 15.7" screen, an intuitive interface, and unparalleled image quality is changing the way healthcare providers practice medicine. www.terason.com | ||
109 |
||
| The Permanente Medical Group (TPMG) is the largest medical group in the United States—and one of the most distinguished. Our 9,300 physicians and 40,000 nurses and staff are leading the transformation of health care. Through nation-leading quality, preeminent research, and superior technology systems, we are delivering superior clinical outcomes, and having a positive and often life-changing impact on the health of our 4.4 million patients in Northern California. In partnership with Kaiser Foundation Hospitals and Health Plan in Northern California, we are a leader in disease prevention, early intervention and world-class specialty care treatment, including cardiovascular, perinatal and neurosurgical care, sepsis survival, and more. Our physicians innovate every day for better outcomes for patients, supported by some of the most comprehensive disease registries in the world and an integrated health care model. From our world-class electronic health record to a seamless care experience for our patients, we set the standard in health care. Learn more about practicing throughout Northern and Central California by visiting http://tpmg.permanente.org or e-mailing us at MDRecruitment.TPMG@kp.org | ||
208 |
||
| The US Oncology Network brings advanced care, cutting-edge research and nearly 1,400 oncologists to the treatment of approximately 900,000 cancer patients each year. With our shared commitment to providing evidence-based treatment to communities across the nation, we believe that together is a better way to fight. | ||
229 |
||
| Table-mounted Breast Retractor System now available! Thompson Surgical celebrates 55 years as a leader in exposure and the original manufacturer of the table-mounted retractor. We understand the value of exposure in surgery and are dedicated to providing innovative, high quality systems that deliver safe, versatile, and low-profile retraction. | ||
210 |
||
| TransMed7, LLC is focused on the highly efficient development of innovative, minimally invasive medical devices. With particular expertise in oncologic, regenerative, and cardiovascular disease, the TransMed7 team has developed a portfolio of next-generation platform devices that are expected to be market leaders in their targeted fields of medicine. | ||
223 |
||
| Vector Surgical is the global leader in tissue orientation devices that provide the most accurate designation of excised tissue margins in cancer surgery. Our devices integrate the needs of surgeons, pathologists and radiologists providing unparalleled tools that enable the highest level of care for their cancer patients. Leading hospitals and physicians are eliminating error and supporting successful surgical outcomes from the OR through recovery with Vector Surgical's Tissue Orientation System: MarginMarker(TM) sterile ink kit, CorrectClips(TM) radiographic markers and the SilversteinWrap(TM). Vector Surgical's innovative devices deliver: * More accurate re-excisions * Fewer unnecessary re-excisions * Lower cancer recurrence * Reduction in post-surgical complications * Improved cosmesis * Cost effective approach to specimen orientation | ||
428 |
||
| Videra Surgical is an oncology surgery company focused on breast cancer treatment. In collaboration with the Cleveland Clinic, Videra developed VeraForm® to enhance cancer treatment. We strongly believe that helping radiation oncologists better identify the tumor bed is essential for the continuum of care for breast cancer patients and many others. VeraForm is an adaptable tissue marker comprised of a radiopaque filament that provides a continuous, 3-dimensional, multi-plane and permanent mark of a tumor bed. Taking a surgeon about 2 minutes to deploy, VeraForm is easily viewed by the radiation oncologist under X-ray and CT/CBCT, but it does not create artifact in MRI or ultrasound, as it is completely metal-free. VeraForm is 510(k) cleared and has been placed in thousands of patients in a rapidly growing number of U.S. centers. VeraForm is designed to provide a precise depiction of the tumor bed, allowing radiation oncologists to be more targeted in the delivery of radiation, in an attempt to avoid over-radiating and possibly damaging collateral tissue and organs. | ||
414 |
||
| Volpara provides an advanced AI software platform that works with a healthcare provider’s expertise to enable a high-quality, optimized, and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient’s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations including FDA clearance and CE marking, and is validated by a volume of peer-reviewed publications unrivaled in the breast screening industry. | ||
511 |
||
| As a breast imaging professional, you are concerned about the risk of re-excision with breast conserving surgery. You want to avoid resurgery and improve your patient’s chances of recovery at all costs. You can achieve that goal with the smarter specimen imaging solutions developed by Xeos. With the XEOS AURA 10, the first-ever PET-CT specimen imager for the OR, we have made it possible to obtain reference image quality in the OR within minutes after excision. Discover the benefits of the AURA 10 PET-CT specimen imager and how Xeos is taking a huge step forward in surgical oncology. Founded in Ghent, Belgium in 2019, Xeos has grown to become a team of bright and passionate minds. We host a wealth of competence in the medical device industry, medical image reconstruction and processing, and fundamental scientific research. We hold a strong track record of inhouse PET & CT design. We are adepts of molecular imaging | ||
204 |
www.zeiss.com/meditec/us/products/intraoperative-radiotherapy.html |
|
| The medical technology business of ZEISS offers future-oriented technologies for intraoperative radiotherapy. The INTRABEAM system, which can be managed by a single radiation oncologist, enables a targeted, risk-adapted and interdisciplinary treatment of tumors. A shortened overall treatment regime can reduce associated side-effects and enhance the comfort of the treatment for the patient. | ||
